Ironman Registry (Prostate Cancer) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn more about prostate cancer and whether certain treatments are related with different outcomes and patient experiences.

What is the Condition Being Studied?

Advanced Prostate Cancer

Who Can Participate in the Study?

Adult patients who have advanced prostate cancer

Age Group

What is Involved?

If you choose to join this study, you will:

  • Have your cancer-related experiences tracked as you undergo standard treatment for your prostate cancer
  • Answer questions about your treatment and experience every three months for two years then every six months for a minimum of three years
  • Have blood samples that will be collected before study entry, at each treatment change, after 1 year of participation, and after 2 years of participation

Study Details

Full Title
IRONMAN: International Registry for Men with Advanced Prostate Cancer
Principal Investigator
Medical Oncologist
Protocol Number
IRB: PRO00080554
NCT: NCT03151629
Phase N/A
Enrollment Status
Open for Enrollment